Cargando…
Evaluation of Crushed Ticagrelor Tablet Doses: Recovery Following Crushing and Naso-gastric Tube Passage Ex Vivo
BACKGROUND: Orally available ticagrelor in combination with low-dose aspirin (75–100 mg/day) is indicated for adult patients with acute coronary syndromes. However, patients with swallowing difficulties may be unable to consume the currently available 90-mg tablet. It is hypothesized that ticagrelor...
Autores principales: | Crean, Barry, Finnie, Cindy, Crosby, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing AG
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3689919/ https://www.ncbi.nlm.nih.gov/pubmed/23737454 http://dx.doi.org/10.1007/s40268-013-0018-4 |
Ejemplares similares
-
On crushing of deutetrabenazine tablets
por: Knebel, Helena, et al.
Publicado: (2021) -
Drug loss while crushing tablets: Comparison of 24 tablet crushing devices
por: Thong, Min Yew, et al.
Publicado: (2018) -
Stability of crushed tedizolid phosphate tablets for nasogastric tube administration
por: Kennedy, G, et al.
Publicado: (2015) -
Stability of Crushed Tedizolid Phosphate Tablets for Nasogastric Tube Administration
por: Kennedy, Gerard, et al.
Publicado: (2015) -
An open-label, randomized bioavailability study with alternative methods of administration of crushed ticagrelor tablets in healthy volunteers
por: Teng, Renli, et al.
Publicado: (2015)